Pharma Equity Group
0.09 DKK
Less than 1K followers
PEG
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Dividend
0.00 %
-11.00 %
-4.71 %
-4.91 %
-23.93 %
-36.20 %
-80.65 %
-80.96 %
-99.66 %
Pharma Equity Group develops medicines for the treatment of serious and life-threatening inflammatory diseases for which there is currently no adequate treatment. The Company uses repositioning of existing medicines and takes drug candidates to a clinical Phase III stage, after which they are handed over to a strategic partner who will complete the development of the products and bring them to market, either independently or in collaboration with the Company.
Read moreMarket cap
109.25M DKK
Turnover
-
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Coverage
Latest research
Latest analysis report
Released: 2025-09-10
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
16/4
2026
General meeting '26
14/8
2026
Interim report Q2'26
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types
Pharma Equity Group A/S - Annual Report 2025
UPDATE OF THE FINANCIAL CALENDAR FOR 2026
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
